TY - JOUR T1 - Pneumococcal conjugate vaccine for adults: “It's tough to make predictions, …” JF - European Respiratory Journal JO - Eur Respir J SP - 1265 LP - 1268 DO - 10.1183/13993003.01038-2015 VL - 46 IS - 5 AU - Mathias W. Pletz AU - Tobias Welte Y1 - 2015/11/01 UR - http://erj.ersjournals.com/content/46/5/1265.abstract N2 - “… especially about the future.” This frequently used Yogi Berra quote also holds true for the paper by Mangen et al. [1] from the Netherlands, which modelled the cost-effectiveness of a potential vaccination programme for elderly adults using the 13-valent pneumococcal conjugate vaccine.Do the results of the CAPITA study justify the general vaccination of adults with PCV13? http://ow.ly/RW74TWe would like to thank Alexander Kuhlmann (Centre for Health Economics, Hannover, Germany) for intense and fruitful discussions. ER -